Exchange: NASDAQ·Updated 05:57 PM EDT

ADIL Adial Pharmaceuticals Inc

$3.88
$0.07
(1.76%)
Today
Closed $3.90
$0.02
(0.51%)
After Hours
Mkt Cap$10.42M
Vol3,043.00

About ADIL

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.
51

Neutral Sentiment

How do you feel about ADIL?

Patrik605
$ADIL It’s exhausting watching this stock. Only 3,000 shares trade daily... yet management gets handed tens or even hundreds of thousands of shares, and we still don't know who was hired or even what their role is. The stock might be in the green all day, only to slip into the red right before the market closes. The company’s progress—and any moves it makes—are painfully slow, but when it comes to handing out shares to management, they act instantly. You buy shares with your hard-earned money, only to see someone else get over 300,000 shares for free—without you even knowing their name, let alone their job title.
focafoca99
$ADIL granted a new employee stock option award of 155,446 shares as an inducement under Nasdaq Rule 5635(c)(4).
Patrik605
$ADIL A bunch of amateurs... Instead of trying to attract investors—since hardly anyone is buying their shares—they’re handing shares out to each other like it’s an assembly line!
Patrik605
$ADIL Instead of news about them constantly handing out shares to one another, Carry could perhaps showcase his achievements and surprise us with something new before he actually packs his bags—since, after a year and two months, he has hardly any successes to his name.
focafoca99
$ADIL recorded shareholder approval to increase authorized common shares from 100M to 500M and adopt new equity incentive plans.
focafoca99
$ADIL clarifies amendment to its purchase agreement removing penalty provision, changing warrant accounting to regain Nasdaq compliance.

Advertisement|Remove ads.